NASDAQ:SGNT (SGNT) (SGNT) Stock Price, News & Analysis → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Free SGNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$21.76▼$21.7650-Day Range N/A52-Week Range$10.55▼$21.88VolumeN/AAverage Volume607,514 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (SGNT) alerts: Email Address Ad Porter & CompanyAI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. About (SGNT) Stock (NASDAQ:SGNT)Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.Read More Ad Porter & CompanyAI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. SGNT Stock News HeadlinesNovember 22, 2023 | msn.comFairfield man arrested in connection to Monday’s Vallejo shootingAugust 22, 2023 | investing.comNihar Info Global Ltd (NIHR)March 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.May 8, 2023 | thestreet.comChanging Landscape for Generic-Drug Makers Creates OpportunitiesApril 30, 2023 | msn.comTrying to find someone to take out all the caulking around my windows outside and redo, replace some cedar siding and all corners have holes from woodpeckers.April 15, 2023 | msn.comOlivia Wilde will helm a tv adaptation of A Visit from the Goon SquadApril 4, 2023 | msn.comNo One Cares About Kamala HarrisMarch 12, 2023 | msn.com'Please be patient': MBTA update on speed restrictionsMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 10, 2023 | msn.comChicago River Dyeing 2023, St. Patrick's Day Parade To Take Place This WeekendFebruary 22, 2023 | technews.tmcnet.comLatticeFlow AG Appoints Global Technology Executive, Andre Boisvert, As Chairman of The BoardJanuary 2, 2023 | thestreet.comSagent Pharmaceuticals (SGNT) Soared Today on Nichi-Iko DealDecember 3, 2022 | msn.comWC Daily Preview: USA/NED, ARG/AUS open Round of 16September 20, 2022 | investing.comSalora International Ltd (SALI)September 15, 2022 | msn.comCharacter Designs That Drastically ChangedAugust 9, 2022 | msn.comJane Seymour hails close friend Olivia Newton-John for ‘changing the world’August 8, 2022 | msn.comWhat On Earth Will A Live-Action Pac-Man Movie Look Like?July 14, 2022 | investing.comSungold Capital Ltd (SUNG)December 2, 2021 | bbc.co.ukJeane Freeman: Inside The PandemicNovember 13, 2021 | dailymail.co.ukCleo Smith: Terrified neighbour of alleged doll-obsessed kidnapper fears locals will burn down houseNovember 11, 2021 | dailymail.co.ukCleo Smith: Forensics spray substance in Carnarvon, WA as Mark McGowan shoots down $1million rewardNovember 9, 2021 | dailymail.co.ukCar of Cleo Smith's alleged abductor becomes focus of investigation as officers scour phone recordsNovember 8, 2021 | msn.comHero detective who found missing girl Cleo Smith visits family homeNovember 8, 2021 | dailymail.co.ukHero detective who led Cleo Smith's rescue visits family home ahead of a week of crucial interviewsSee More Headlines Receive SGNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (SGNT) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/04/2015Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:SGNT CUSIP78669210 CIK1369786 Webwww.sagentpharma.com Phone+1-847-9081604FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report SGNT Stock Analysis - Frequently Asked Questions How were (SGNT)'s earnings last quarter? (SGNT) (NASDAQ:SGNT) issued its earnings results on Tuesday, August, 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.06. The firm had revenue of $77.30 million for the quarter, compared to analyst estimates of $83.28 million. The business's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.09 EPS. What other stocks do shareholders of (SGNT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (SGNT) investors own include Mazor Robotics (MZOR), Endocyte (ECYT), Inovio Pharmaceuticals (INO), Surgery Partners (SGRY), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC), Daré Bioscience (DARE) and Dynavax Technologies (DVAX). This page (NASDAQ:SGNT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (SGNT) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.